Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
The DOI matches its Crossref record; 484 of the 491 references it cites were found in a registry or an index.
Abstract
Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2 diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin resistant, metformin was introduced in clinical practice to treat these patients also. Moreover, metformin's effect has other targets beside its insulin-sensitizing action. The present review was aimed at describing all evidence-based and potential uses of metformin in PCOS patients. In particular, we will analyze the uses of metformin not only for the treatment of all PCOS-related disturbances such as menstrual disorders, anovulatory infertility, increased abortion, or complicated pregnancy risk, hyperandrogenism, endometrial, metabolic and cardiovascular abnormalities, but also for the prevention of the syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the beneficial effects of metformin are increasingly evident, especially when combined with lifestyle modifications, improving the pathogenetic mechanisms underlying PCOS, restoring ovarian function, and improving metabolic profile, especially insulin sensitivity and, unlike COCs, lipoprotein pattern [49].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [49]
In the citing paper
“Metformin has been used extensively in DM2, is the most studied in PCOS, and has the most reassuring safety profile. 222”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [222]
Citations
Cites
4 retracted
Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M.-H., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 478
RetractedClomiphene citrate for ovulation induction in women with oligo-amenorrhoea
Hughes, E. G., Collins, J. A., & Vandekerckhove, P. (1996) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000056 · Cited by 75
RetractedWei, Z., Cao, Y., Cong, L., Zhou, P., Zhang, Z., & Li, J. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.07.1385 · Cited by 37
RetractedKoçak, İ., & Üstün, C. (2006) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2006.00401.x · Cited by 24
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Research works printed but not linked: 5
- 2005, American Association of Clinical Endocrinologists position statements on metabolic and cardiovascular consequences of polycystic ovary syndrome., Endocr Pract, 11, 126
- Deaton, 1991, Hyperandrogenism and uterine bleeding., Infertil Reprod Med Clin North Am, 2, 561
- 1992, Recent advances in medically assisted conception., WHO Tech Rep Ser, 820, 1
- Sonntag, 2005, Metformin alters insulin signaling and viability of human granulosa cells., Fertil Steril, 84, 1173, 10.1016/j.fertnstert.2005.04.043 · DOI
- Koschinsky, 1988, Influence of metformin on vascular cell proliferation., Diabetes Metab, 14, 566
Cited by
Items 301–400 of 426
Secondary PCOS: Well-defined causes, leading to the PCOS phenotype
Gambineri, A., Cecchetti, C., Altieri, P., Ribichini, D., Preiato, V. L., Fanelli, F., & Pagotto, U. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00008-0 · Cited by 4
The Pathology of Experimental Rhoodococcus equi infection in foals
Al-Salihi, K. A., Al-Izzi, S. A. L., & Al-Darraji, A. M. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22428/mrvsa
Flavonoids and polycystic ovary syndrome
Shen, H., & Liu, Y. (2026) · Food & Function · doi:10.1039/d5fo04823k · Cited by 4
Sharata, E. E., Abdel-Samea, A. S., Ibrahim, L. Y., Mamdouh, M., Khalid, N., Rabea, M., Mohamed, G. H., Abdelnaser, M., & Mohyeldin, R. H. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05559-4 · Cited by 3
Oral contraceptives in polycystic ovarian syndrome: the long and short of it
Nader, S. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.88 · Cited by 3
Matossian, G. A., Buklarewicz, I. M., & Moosa, V. A. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.483 · Cited by 5
Hara, S., Takahashi, T., Igarashi, H., Amita, M., Matsuo, K., Hasegawa, A., & Kurachi, H. (2014) · Journal of Mammalian Ova Research · doi:10.1274/jmor.31.2 · Cited by 3
Insulin sensitizers for women with polycystic ovarian syndrome
Galal, A. F., & Mitwally, M. F. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.4.2.183 · Cited by 4
Stracquadanio, M., & Ciotta, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16760-2_6 · Cited by 3
Ovarian hyperstimulation syndrome
Palomba, S., & Caserta, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89907-9.00009-0 · Cited by 4
Self-citationOvarian Function and Obesity: PCOS, Menopause
Lubrano, C., Gnessi, L., & Migliaccio, S. (2014) · Springer eBooks · doi:10.1007/978-3-319-09045-0_7 · Cited by 3
“Metformin is well known to improve the ovarian response to clomiphene citrate, improve the likelihood of mono-ovulatory cycles and lower the risk of ovarian hyperstimulation syndrome [47].”
BackgroundReply: Polycystic ovary syndrome and pregnancy
Palomba, S., deWilde, M. A., Falbo, A. I., Koster, M. P. H., Sala, G. B. L., & Fauser, B. C. J. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv052 · Cited by 3
“Metformin has been proposed to improve insulin sensitivity in pregnant women with PCOS (Palomba et al., 2009; Sivalingam et al., 2014).”
BackgroundSelf-citationIs metformin effective and safe during pregnancy in women with PCOS? An overview of reviews
Palomba, S., Seminara, G., Costanzi, F., Sculli, M. A., Alessi, E., Caserta, D., & Aversa, A. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2574334 · Cited by 7
“Thus, metformin may be considered as preventive treat-ment in these patients impacting their future health [17].”
Self-citationKumar, R., Seshadri, K., & Pandurangi, M. (2016) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20160852 · Cited by 2
Ali, B. H., Khalaf, B. H., & Almaali, H. M. M. A. (2021) · Medico-Legal Update · doi:10.37506/mlu.v21i2.2680 · Cited by 3
“Metformin is an off-label medication used in PCOS patients as an insulin sensitizer(3).”
BackgroundGoldstein, T., Ott, J., Katzensteiner, P., Krysiak, R. G., Marculescu, R., Boegl, M. S., & Hager, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247781 · Cited by 6
“Furthermore, metformin has been shown to improve weight reduction when combined with lifestyle modification [7], and can therefore also be used to induce ovulation [8].”
Estados hiperandrogénicos: revisión de la literatura
Villarreal-Tordecilla, G. A. (2009) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.319 · Cited by 3
Polycystic Ovary Syndrome: Update on Treatment Options and Treatment Considerations for the Future
Farrell-Turner, K. A. (2011) · Clinical Medicine Insights Women s Health · doi:10.4137/cmwh.s6715 · Cited by 3
Jakiel, G., Bijok, J., & Bińkowska, M. (2014) · Ginekologia Polska · doi:10.17772/gp/1765 · Cited by 2
Metformin: Nature′s gift that keeps on giving more!
Balasubramanyam, M. (2014) · Journal of Obesity and Metabolic Research · doi:10.4103/2347-9906.134428 · Cited by 2
Infertility in women with polycystic ovary syndrome and the role of metformin in management
Boyle, J. A., Teede, H. J., & Misso, M. L. (2013) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2013.842689 · Cited by 2
Polycystic Ovary Syndrome: Explaining the Gynecological Aspects and Treatment Options to Patients
Reid, R. L. (2015) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/2/4/00132 · Cited by 1
“Metformin can delay the onset of diabetes by increasing insulin sensitivity [46,47].”
BackgroundRastegar, F., Rezaee, Z., Saedi, N., Memari, R., & Tajpour, M. (2021) · Biomedical Research and Therapy · doi:10.15419/bmrat.v8i12.710 · Cited by 2
Ibrahim, Y. F., Toni, N. D. M., Thabet, K., Hegazy, A., & Bahaa, H. A. (2020) · Minia Journal of Medical Research · doi:10.21608/mjmr.2022.221583 · Cited by 5
“However, parallel to these benefits, metformin also has side issues including lactic acidosis, gastro-intestinal disturbances, mode changes, memory loss, and renal insufficiency (Palomba et al., 2009).”
BackgroundPCOS and Insulin Resistance (IR): From Lifestyle to Insulin Sensitizers
Genazzani, A. D., Santagni, S., Rattighieri, E., Chierchia, E., Despini, G., Prati, A., & Ricchieri, F. (2014) · ISGE series · doi:10.1007/978-3-319-09662-9_2 · Cited by 3
Metformin: od mehanizmov delovanja do napredne klinične uporabe
Janić, M., Volčanšek, Š., Lunder, M., & Janež, A. (2017) · Slovenian Medical Journal · doi:10.6016/zdravvestn.1503 · Cited by 4
Androgens and Severe Insulin Resistance States: Basic and Clinical Aspects
Gambineri, A., Zanotti, L., & Gasparini, D. I. (2019) · Frontiers of hormone research · doi:10.1159/000494911 · Cited by 2
Bailey, C. J., & Krentz, A. J. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch31 · Cited by 2
Effect of metformin on the endometrial proteome of diet-induced obese mice
Malliou-Becher, M.-N., Turnwald, E., Skupin, L., Kretschmer, T., Mesaros, A., Purrio, M., Wohlfarth, M., Handwerk, M., Kalis, S., Gründemann, D., et al. (2025) · Journal of Molecular Endocrinology · doi:10.1530/jme-24-0098 · Cited by 1
Vârciu, A.-G. (2025) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2025-0050 · Cited by 1
Yegane, D. F., Bahramikia, S., Babaeenezhad, E., & Dezfoulian, O. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02316-0 · Cited by 1
“…of PCOS, includ - ing weight gain, acne, and hirsutism (Saadati et al. 2025), and prolonged use may be associated with adverse effects, such as gastrointestinal disturbances (Palomba et al. 2009), vitamin B12 deficiency (Infante et al. 2021), and, in rare cases, lactic acidosis (See 2024).”
Irfan, N. U. A., Saleem, S., & Irfan, A. (2026) · Clinical Endocrinology · doi:10.1111/cen.70188 · Cited by 2
La metformina y sus aplicaciones actuales en la clínica
Castro-Martínez, M. G., Anaya, V. C., Ochoa-Aguilar, A., & Gutiérrez, S. (2014) · Medicina Interna de México · Cited by 11
Abnormal Uterine Bleeding in Adolescence
Park, H. T., & Kim, Y. T. (2009) · Journal of Korean Medical Association · doi:10.5124/jkma.2009.52.8.779 · Cited by 1
Montplaisir, P. (2011) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2011.00651.x · Cited by 2
“At present, the length of treatment for metformin is not standardized and no model is available to calculate dose (Palomba et al., 2009).”
BackgroundNivethitha, T., & Vijayalakshmi, S. P. (2015) · International Journal of Pharma and Bio Sciences · Cited by 1
Mazza, D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3871-8.10006-2 · Cited by 1
Prescription pattern of metformin for various indications: a prospective study
Vaseem, A., Ali, M., & Afshan, K. (2017) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20174659
“Meta-analysis of several trials showed that metformin treatment increases ovulation, improves menstrual cyclicity, decreases FSH stimulated steroidogenic enzymes and aromatase activity, thereby reducing hyperinsulinaemia and hyperandrogenaemia in PCOS patients.(14)”
BackgroundDhaliwal, J. (2022) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.409 · Cited by 2
Fatima, Q., Jeelani, H., Abass, S., Farooq, M., & Rashid, F. (2023) · Springer eBooks · doi:10.1007/978-981-99-2193-5_9 · Cited by 3
张, 楚. (2023) · Traditional Chinese Medicine · doi:10.12677/tcm.2023.129374 · Cited by 1
Kumawat, B. L., Kumar, P., Mahla, A. S., Kumar, A., Kumar, A., Singh, R., & Kumar, A. (2023) · Veterinary Research Communications · doi:10.1007/s11259-023-10259-y · Cited by 3
Bomba-Opon, D. A., Gutaj, P., Kędzia, M., Leszczyńska‐Gorzelak, B., Majewska, A., Radzicka, S., Stanirowski, P. J., & Wender-Ożegowska, E. (2023) · Ginekologia Polska · doi:10.5603/gpl.97361 · Cited by 6
Polycystic Ovary Syndrome in the Non-Gynaecological Practice – Can We Use a Common Medical Approach?
Petrnyi, G. (2012) · InTech eBooks · doi:10.5772/25983 · Cited by 1
“discussion in favour of the use, including long-term use of metformin in PCOS for all possible aspects, indications, contraindications, and safety issues has also been published in growing numbers (Diamanti-Kandarakis et al., 2010; Nestler, 2008; Palomba et al., 2009) including metformin taking during pregnancy and la…”
BackgroundRôle de la metformine dans le SOPK
Duranteau, L., Lefevre, P., Jeandidier, N., Simon, T., & Christin‐Maître, S. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.12.006 · Cited by 3
Integrated Strategies for Enhancement of Fertility in PCOS
Coghlan, E., & Hart, R. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_21 · Cited by 2
Palomba, S., & Fauser, B. C. J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_22 · Cited by 1
Self-citationHusseinand, M. R., Abdulwahid, H. H., Abo Almaali, H. M., & Ouda, M. H. (2021) · PLANT ARCHIVES · doi:10.51470/plantarchives.2021.v21.s1.004 · Cited by 1
Polycystic Ovary Syndrome: Crossing the Frontiers in Management
Ahmad, A. K., & Khan, T. (2022) · International Journal of Human and Health Sciences (IJHHS) · doi:10.31344/ijhhs.v6i4.474 · Cited by 2
Urhan, E., Elbüken, G., Hacıoğlu, A., Karaca, Z., Unluhizarci, K., & Keleştimur, F. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01946-9 · Cited by 1
A Comparative Study of Myoinositol and Metformin for Ovulation Induction in Pregnant Women with PCOS
Johra, T. H., Akther, N., Rabeya, S., Khan, M. A. H. K., & Amanullah, M. (2023) · East African Scholars Journal of Medical Sciences · doi:10.36349/easms.2023.v06i01.005
Canpolat, A. G., Aslan, B., & Şükür, Y. E. (2023) · HORMONES · doi:10.1007/s42000-023-00469-z · Cited by 1
“Furthermore, both LH and insulin lead to theca cell hyperplasia [13].”
BackgroundBruk av metformin ved polycystisk ovarie-syndrom
Carlsen, S. M. (2009) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.08.0663 · Cited by 1
Surgical Management Options for Patients with Infertility and Endometriosis
Catenacci, M., & Falcone, T. (2010) · Current Women s Health Reviews · doi:10.2174/157340410791321363 · Cited by 1
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome
Cascella, T., Palomba, S., Giallauria, F., de Sio, I., Colao, A., Lombardi, G., Orio, M., & Orio, F. (2009) · Clinical Lipidology · doi:10.2217/clp.09.55 · Cited by 1
Self-citationEffects of Prenatal Testosterone on the Reproductive and Metabolic Neurons of the Sheep Hypothalamus
Cernea, M. (2013) · Scholarship@Western (Western University)
Menstrual Cycle Disturbances at Reproductive Age
Piotr, S. (2011) · InTech eBooks · doi:10.5772/16993
“Lactic acidosis is a rare complication of metformin administration (5.1 cases per 100 000 patient-years), although when it occurs, mortality of 50% has been observed (Palomba et al., 2009).”
BackgroundInfluentialEmerging concepts in metformin therapy: Hyperglycaemia and beyond
Fiad, T. M., Hammadi, F. A., Nuaimi, A. A., & Dhuhouri, J. A. (2013) · Ibnosina Journal of Medicine and Biomedical Sciences · doi:10.4103/1947-489x.210550
Nebennieren und Diabetes mellitus
Weismann, D., & Allolio, B. (2009) · Der Diabetologe · doi:10.1007/s11428-009-0436-7
Metformin bei Antipsychotikainduzierter Amenorrhoe
Gahr, M., & Baumgarten, E. (2013) · Nervenheilkunde · doi:10.1055/s-0038-1628541
The use of metformin in ART for PCOS patients
Elnashar, A. M. (2010) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2010.08.001
Li, C., Cheng, J., Wang, J., Xue, Y., Huang, Z., Zhang, S., & Lv, J. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1924-8
“sensitizing mechanisms may be involved [10].”
BackgroundPrise en charge à l’âge adulte des patients avec un bloc en 21 hydroxylase
Christin‐Maître, S. (2013) · Médecine Nucléaire · doi:10.1016/j.mednuc.2012.11.002
Machado, A. D. B. (2013) · Americanae (AECID Library) · Cited by 1
A Systematic Review and Meta-Analysis of Acarbose in the Treatment of Polycystic Ovary Syndrome
Wang, L., Han, T., Yue, J., Liu, W., & Hu, Y. (2014)
evaluating the infertile Patient: An evidence-Based Review
Trolice, M. P. (2011)
Metformin in gestational diabetes mellitus
Tertti, K. (2013) · UTUPub (University of Turku)
Singh, S., Singh, S., & Ashraf, C. M. (2015) · Springer eBooks · doi:10.1007/978-81-322-1686-5_5
Woo, Y. S., & Bahk, W. (2013)
Reproductive endocrinology and infertility
OLSEN, M. E., & Rizk, B. M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316084380.027
Nemati, M., & Nemati, S. (2016) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.1000191 · Cited by 1
“Although, the biological mechanisms of metformin on reduction of BMI is still largely unknown, but some experimental studies have demonstrated that metformin reduces body weight and BMI by decreasing insulin resistance and modulating the level of various peptides involved in controlling appetite like ghrelin, neuropep…”
BackgroundBjekić-Macut, J., Antić, I. B., Milutinović, D. V., Stanojlović, O. P., Andric, Z. G., Ilić, D., & Μacut, D. (2015) · Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor · doi:10.5937/medgla1556007b
Mayer, M. (2016) · TSpace (University of Toronto)
Predictors of success and optimization of treatment in infertile PCOS patients
Palomba, S., Falbo, A. I., & Sala, G. B. L. (2013) · doi:10.2217/ebo.12.174
Self-citationSerum Uric Acid Concentration in Patients with Polycystic Ovary Syndrome Treated by Metformin
Al-Hussaini, A. J., & Abdullah, R. G. (2012) · Iraqi Journal of Community Medicine
Palomba, S., Falbo, A. I., & Sala, G. B. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_11
Self-citationManagement of menstrual disorders and endometrial hyperplasia
Lombardi, G., Stasi, V. D., Volpe, A., Savastano, S., Colao, A., & Orio, F. (2013) · doi:10.2217/ebo.12.195
Self-citationThe effect of metformin on clinical features of women with polycystic ovary syndrome
Bilibajkić, M., Antić, I. B., & Μacut, D. (2018) · Medicinski podmladak · doi:10.5937/mp69-17816
“Glavni mehanizam dejstva metformina je inhibicija glukoneogeneze u jetri i poboljšanje insulinske senzitivnosti u perifernim tkivima (11).”
BackgroundNew pharmacological approaches in type 2 diabetes mellitus
Cusi, K. J. (2009) · Dialnet (Universidad de la Rioja) · doi:10.1016/b978-84-8086-683-5.50016-0
Oral contraceptives: indications and cautions
Nader, S. (2013) · doi:10.2217/ebo.12.238
Al-Salem, A. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-49984-6_14
Chang, C. C., & Chang, Y. K. (2020) · Authorea · doi:10.22541/au.159363405.56857931
“Metformin modifies the ovarian morphology in PCOS [27], enhances intraovarian androgen levels [28], and improves systemic and local insulin resistance [29].”
Dhillo, W. S., Davies, M. C., Jayasena, C. N., & Seal, L. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198851899.003.0004
(2009) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3283339a65
Stracquadanio, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-29223-2_4
Dorra, T., Chamiah, S., Mansour, A., & Atwa, A. (2021) · Journal of Animal and Poultry Production · doi:10.21608/jappmu.2021.219985
“In this way, the advancement of the hyperinsulinemic and hyperandrogenic ovarian environment may be significant for a ordinary folliculogenesis, homogeneous improvement, and responsiveness of follicles and atresia of the little cohort of follicles (Palomba et al, 2009).”
BackgroundSocio-demographic Criteria of Children Exposed Versus Non-exposed to Passive Smoking
Bebars, G. M., Omar, S. M. A., Ibrahem, M., & Ahmed, H. (2019) · Minia Journal of Medical Research · doi:10.21608/mjmr.2022.221759
Wass, J. A. H., Owen, K. R., & Turner, H. E. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199644438.003.0004
Polycystic Ovary Syndrome: An Update on Management Strategies
Aftab, M., Inzamam, M., & Latif, S. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22164654 · Cited by 1
Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?
Hamadneh, J., Amarin, Z. O., Alchalabi, H., Al-Bayyari, N. S., & Hamadneh, S. (2022) · Biomedical Reports · doi:10.3892/br.2022.1553
“As suggested by Palomba et al (26), the results of this study suggest that it would be reasonable to use Metformin as a first‐line therapy in women, with relative contraindication to the long term use of the combined oral contraceptive pill, who wish to have regular menstruation, where menstruation is simply a withdra…”
QUALITY OF LIFE USING DERMATOLOGY LIFE QUALITY INDEX IN FEMALE PATIENTS WITH HIRSUTISM
ULLAH, M., Iqbal, R., & RAFIQUE, S. (2023) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2023i1.203
“Prompt diagnosis and urgent treatment may reduce the burden of disease (Palomba et al., 2009).”
Bahadori, F., Sadatmahalleh, S. J., Montazeri, A., Nasiri, M., & Moieni, A. (2023) · Research Square · doi:10.21203/rs.3.rs-2820500/v1
Rezeg, H. S., Alsaliheen, A. A., & Elmahaishi, M. (2023) · Archives of Clinical Trials · doi:10.33425/2768-4598.1033
“The effect of metformin on body weight and fat distribution in PCOS patients is unclear, as some studies have shown a decrease in weight and waist circumference, while others have not [42].”
BackgroundHamadneh, J., Al-Bayyari, N. S., Hamadneh, S., Amarin, Z. O., & Alchalabi, H. (2024) · doi:10.22541/au.170664908.85156664/v1
Urbanetz, L. A. M. L. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2024.tde-05082024-124157
Efficacy of Metformin in Treating Complications Associated with Polycystic Ovary Syndrome (PCOS)
Alduraywish, R. A., & Al‐Sowayan, N. S. (2024) · Advances in Aging Research · doi:10.4236/aar.2024.136011
Metadata
- Authors
- Palomba, S., Falbo, A., Zullo, F., & Orio, F.
- Affiliations
- Magna Graecia University (IT)
- Parthenope University of Naples (IT)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-12-04
- Volume
- 30
- Issue
- 1
- Pages
- 1-50
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2160472557
- Cited by
- 426
- References
- 491
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 20 · 2023: 28 · 2022: 25 · 2021: 18 · 2020: 15 · 2019: 19 · 2018: 19 · 2017: 15 · 2016: 18 · 2015: 26 · 2014: 37 · 2013: 40 · 2012: 33
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- CINECA IRIS Institutial research information system (Parthenope University of Naples) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- metformin, polycystic ovary syndrome, insulin sensitization, insulin resistance, menstrual disorders, anovulatory infertility, pregnancy complications, hyperandrogenism, endometrial abnormalities, cardiovascular risk, PCOS prevention, type 2 diabetes
- MeSH terms
- Anovulation, Cardiovascular Diseases, Endometrium, Female, Humans, Hypoglycemic Agents, Menstruation Disturbances, Metformin, Obesity, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Complications, Quality of Life, Endometrial Neoplasms, Hyperandrogenism, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.